Norton W L
Spine (Phila Pa 1976). 1986 Jun;11(5):440-3.
A retrospective review of insurance claim files was conducted to compare the costs of chemonucleolysis with surgical discectomy. Twenty-nine surgeons performed 61 chemonucleolysis procedures and 44 surgical discectomies on SAIF (State Accident Insurance Fund, Inc.--a major Oregon workers' compensation insurance company) claimants between December 1982 and April 1984. Clinical data and treatment costs were tabulated during February 1985. In this population of 105 workers' compensation claimants, the average cost/claim of the workers treated by chemonucleolysis was higher than the average cost/claim of workers treated initially by surgical discectomy. The average cost/claim was somewhat lower in successful chemonucleolysis cass than in successful surgical discectomy cases, but the average cost/claim of unsuccessful chemonucleolysis cases was much higher than unsuccessful surgical discectomy cases. In order for chemonucleolysis to be a cost effective method compared to initial surgical discectomy, it would be necessary to attain a much higher chemonucleolysis success rate than observed in this group of patients.
对保险理赔档案进行了回顾性研究，以比较化学髓核溶解术和手术椎间盘切除术的费用。1982年12月至1984年4月期间，29名外科医生对俄勒冈州工人赔偿保险基金公司（一家主要的俄勒冈州工人赔偿保险公司）的索赔者进行了61例化学髓核溶解术和44例手术椎间盘切除术。1985年2月将临床数据和治疗费用制成表格。在这105名工人赔偿索赔者中，接受化学髓核溶解术治疗的工人的平均索赔费用高于最初接受手术椎间盘切除术治疗的工人的平均索赔费用。成功的化学髓核溶解术病例的平均索赔费用略低于成功的手术椎间盘切除术病例，但不成功的化学髓核溶解术病例的平均索赔费用远高于不成功的手术椎间盘切除术病例。为了使化学髓核溶解术与最初的手术椎间盘切除术相比成为一种具有成本效益的方法，有必要获得比该组患者中观察到的高得多的化学髓核溶解术成功率。
